Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Behavioural Brain Research
|
August 15, 2000
Altered baroreflex responses in alpha7 deficient mice
D Franceschini, A Orr-Urtreger, W Yu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 24, 2024
Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer
D Franceschini, C Franzese, T Comito, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 19, 2021
Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost
D Franceschini, A Fogliata, R Spoto, et al.
World Journal of Urology
|
October 25, 2014
Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer
B Detti, P Bonomo, L Masi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 21, 2024
Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases
D Franceschini, M A Teriaca, P Mancosu, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 9, 2016
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients
G D'Agostino, C Franzese, F De Rose, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 14, 2022
Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic Radiotherapy
C Franzese, P Navarria, L Bellu, et al.
La Radiologia Medica
|
January 30, 2013
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experience
D Greto, F Paiar, C Saieva, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 29, 2023
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival
C Franzese, R Lucchini, M Roghi, et al.
World Journal of Urology
|
June 12, 2015
CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed
B Detti, P Bonomo, L Masi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Behavioural Brain Research
|
August 15, 2000
Altered baroreflex responses in alpha7 deficient mice
D Franceschini, A Orr-Urtreger, W Yu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 24, 2024
Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer
D Franceschini, C Franzese, T Comito, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 19, 2021
Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost
D Franceschini, A Fogliata, R Spoto, et al.
World Journal of Urology
|
October 25, 2014
Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer
B Detti, P Bonomo, L Masi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 21, 2024
Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases
D Franceschini, M A Teriaca, P Mancosu, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 9, 2016
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients
G D'Agostino, C Franzese, F De Rose, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 14, 2022
Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic Radiotherapy
C Franzese, P Navarria, L Bellu, et al.
La Radiologia Medica
|
January 30, 2013
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experience
D Greto, F Paiar, C Saieva, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 29, 2023
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival
C Franzese, R Lucchini, M Roghi, et al.
World Journal of Urology
|
June 12, 2015
CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed
B Detti, P Bonomo, L Masi, et al.
Page
of 7